Impact of pharmacists ACCESs to clinical information on the quality and the continuity of care in poly-medicamented community patients: a randomised controlled trial

Completed

• Conditions: Drug-related problems from multiple prescription drugs; Signs and Symptoms; Drug-related problems

• Registration Number: ISRCTN74420611
• Lead Sponsor: Pfizer (Canada)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2008-06-18
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 170

Inclusion Criteria

Family doctors or residents:
1. Practicing at the Family Medicine Clinic of CSSS de Laval
2. Agree to participate and sign the consent form

Community pharmacists:
1. Practicing in one of the pharmacies in the area of Laval or surrounding areas
2. Have one or more patients eligible for the study
3. Agree to participate and sign the consent form

Patients:
1. 18 years old or older, either sex
2. Have an appointment at the Family Medicine Clinic of CSSS de Laval between October 2007 and March 2008
3. Takes at least five chronic medications
4. Reports being a patient of one of the participating pharmacies
5. Agrees to participate and sign the consent form
6. Is considered eligible by his family doctor

Exclusion Criteria

1. Is not able to speak or read French
2. Is a patient of more than one community pharmacy
3. Is not able to give a informed consent

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The following will be assessed after two months of follow-up: <br>1. Compare the mean number of DRP per patient identified by community pharmacists in both groups (intervention group and control group)<br>2. Compare the mean number of pharmacotherapy changes per patient between both groups (intervention group and control group)

Secondary Outcome Measures

Name	Time	Method
The following will be assessed after two months of follow-up:<br>1. Compare the proportion of patients in each group for whom at least one intervention was made by the community pharmacists <br>2. For each type of intervention, compare the proportion of interventions made by the community pharmacists in both groups<br>3. Compare the proportion of pharmaceutical opinions that resulted in a pharmacotherapy change in both groups<br>4. Describe and compare the type of contact made between community pharmacists and Family Medicine Clinic?s pharmacists in both groups